--- title: 2023 Patient Access Survey Report description: Explore the 2023 report revealing the impact of state regulations on prescription drug therapy access and affordability. --- [Skip to content](https://www.curatioadvisors.com/2023-patient-access-survey-report#main-content) [![Curatio Logo-2](https://www.curatioadvisors.com/hubfs/Curatio%20Logo-2.png)](https://www.curatioadvisors.com?hsLang=en) ![Toggle Open Icon-1](https://www.curatioadvisors.com/hubfs/Toggle%20Open%20Icon-1.png) ![menu-close](https://21645388.fs1.hubspotusercontent-na1.net/hubfs/21645388/menu-close.svg) - [Home](https://www.curatioadvisors.com) - [Services](https://www.curatioadvisors.com/services) Show submenu for Services - [Pharma Manufacturers](https://www.curatioadvisors.com/services#A-PharmaManuf) - [Specialty & Infusion Pharmacies](https://www.curatioadvisors.com/services#B-SpecialtyInfusion) - [Private Equity](https://www.curatioadvisors.com/services#C-PrivateEquity) - [Pharma Services Providers](https://www.curatioadvisors.com/services#D-PharmaServices) - [Rapid Response](https://www.curatioadvisors.com/rapid-response) - [Advisory Team](https://www.curatioadvisors.com/advisory-team) Show submenu for Advisory Team - [About](https://www.curatioadvisors.com/about-us) - [Become a Curatio Advisor](https://www.curatioadvisors.com/become-a-curatio-advisor) - [Industry Insights](https://www.curatioadvisors.com/industry-insights) Show submenu for Industry Insights - [Reports & Research](https://www.curatioadvisors.com/reports) - [Advisory Briefs](https://www.curatioadvisors.com/insights/advisory-briefs) - [Market Intelligence](https://www.curatioadvisors.com/market-intelligence) - [Events](https://www.curatioadvisors.com/events) - [Contact Us](https://www.curatioadvisors.com/contact-us) - [Home](https://www.curatioadvisors.com) - [Services](https://www.curatioadvisors.com/services) Show submenu for Services - [Pharma Manufacturers](https://www.curatioadvisors.com/services#A-PharmaManuf) - [Specialty & Infusion Pharmacies](https://www.curatioadvisors.com/services#B-SpecialtyInfusion) - [Private Equity](https://www.curatioadvisors.com/services#C-PrivateEquity) - [Pharma Services Providers](https://www.curatioadvisors.com/services#D-PharmaServices) - [Rapid Response](https://www.curatioadvisors.com/rapid-response) - [Advisory Team](https://www.curatioadvisors.com/advisory-team) Show submenu for Advisory Team - [About](https://www.curatioadvisors.com/about-us) - [Become a Curatio Advisor](https://www.curatioadvisors.com/become-a-curatio-advisor) - [Industry Insights](https://www.curatioadvisors.com/industry-insights) Show submenu for Industry Insights - [Reports & Research](https://www.curatioadvisors.com/reports) - [Advisory Briefs](https://www.curatioadvisors.com/insights/advisory-briefs) - [Market Intelligence](https://www.curatioadvisors.com/market-intelligence) - [Events](https://www.curatioadvisors.com/events) - [Contact Us](https://www.curatioadvisors.com/contact-us) This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. ![Toggle Open Icon-1](https://www.curatioadvisors.com/hubfs/Toggle%20Open%20Icon-1.png) ![menu-close](https://21645388.fs1.hubspotusercontent-na1.net/hubfs/21645388/menu-close.svg) ## Reports # 2023 Patient Access Survey Report [know more](https://www.hubspot.com/) - [Home](https://www.hubspot.com/)> - Event Detail **2023 Patient Access: State Legal and Regulatory Environment Survey Report** Given the dynamic nature of state government activity we sought to validate the following: - ![2023 Patient Access Report](https://www.curatioadvisors.com/hs-fs/hubfs/2023%20Patient%20Access%20Report.png?width=206&height=279&name=2023%20Patient%20Access%20Report.png)Patient access to prescription drug therapy is greatly affected by various state and local policy and regulatory parameters. - There is no formalized process or aggregating compendium, at the state level, specifically monitoring policy and regulatory parameters that impact patient access to, and affordability of, drug therapies. - Timely insights into legislation and regulations pertaining to patient access, particularly for high-cost drug therapies will enable more effective decisions regarding the patient’s journey and drug product lifecycle. ### Full Report **Curatio Scientia Advisors releases the “2023 Patient Access: State Legal and Regulatory Environment Survey”** Given the dynamic nature of state government activity we sought to validate the following: - Patient access to prescription drug therapy is greatly affected by various state and local policy and regulatory parameters. - There is no formalized process or aggregating compendium, at the state level, specifically monitoring policy and regulatory parameters that impact patient access to, and affordability of, drug therapies. - Timely insights into legislation and regulations pertaining to patient access, particularly for high-cost drug therapies will enable more effective decisions regarding the patient’s journey and drug product lifecycle.     [![Curatio Advisors Horizontal with White Stroke 2](https://www.curatioadvisors.com/hubfs/Curatio%20Advisors%20Horizontal%20with%20White%20Stroke%202.png)](https://www.curatioadvisors.com/contact-us?hsLang=en) Curatio Advisors is your trusted independent advisory support partners that provides innovative solutions that support access and positive outcomes in the patient journey with complex drug therapies. - [Home](https://www.curatioadvisors.com) - [Services](https://www.curatioadvisors.com/services) - [Advisory Team](https://www.curatioadvisors.com/advisory-team) - [Industry Insights](https://www.curatioadvisors.com/industry-insights) - [Events](https://www.curatioadvisors.com/events) - [Contact Us](https://www.curatioadvisors.com/contact-us) ###### Get In Touch info@curatioadvisors.com - Copyright © 2026 Curatio Scientia Advisors, All Rights Reserved. [Code of Conduct |](https://www.curatioadvisors.com/code-of-conduct?hsLang=en) [Sustainability Policy](https://www.curatioadvisors.com/sustainability-policy?hsLang=en)